Logo

Novartis Hires BioVision to Find Clinically Relevant Peptides

Dec 09, 2004

NEW YORK, Dec. 9 (GenomeWeb News) - BioVision will evaluate clinical samples provided by Switzerland-based Novartis Pharmaceuticals as part of a service agreement, BioVision said today.

 

Germany-based BioVision hopes to find and identify clinically relevant peptides, the company said.

 

Financial terms of the agreement were not disclosed.

Breaking News
The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.